I came to London to report about higher education but I stayed for the austerity.

Glaxo Considers ViiV IPO to Capitalize on HIV-Drug Sales

bloomberg.com — GlaxoSmithKline Plc (GSK) is exploring an initial public offering for its Viiv Healthcare Ltd. subsidiary to capitalize on the unit's soaring sales of HIV drugs even as revenue for the parent company declines. Glaxo is considering the sale of a minority stake, the London-based pharmaceutical maker said in a statement today.

Glaxo Pledges to Cut Costs After Earnings Beat Estimates

bloomberg.com — GlaxoSmithKline Plc (GSK), the U.K.'s biggest drugmaker, reported third-quarter earnings that beat analyst estimates, even as currency effects and sluggish sales of its respiratory drugs in the U.S. hurt profit. Profit excluding certain items fell 1 percent to 1.89 billion pounds ($3 billion), or 27.9 pence a share, the London-based company said today in a statement.

Bloomberg Briefs

bloombergbriefs.folioshack.com — Highclere Thoroughbred Racing, the syndicate that owned former Royal Ascot winner Harbinger, is experiencing strong demand even as higher prices for young racehorses push up costs, managing director Alex Smith said. Highclere, founded in 1992 to put together ownership groups for racehorses, has produced seven champions, including top-rated Harbinger in 2010.

J&J Says 250,000 Ebola Vaccine Doses to Be Ready by May

bloomberg.com — Johnson & Johnson (JNJ) plans to have 250,000 doses of an experimental Ebola vaccine ready for use in clinical trials in May, accelerating the effort to find protection from the virus that has killed thousands of people in West Africa.

Glaxo Rising Star Connelly Under Pressure as Drugs Falter

bloomberg.com — Deirdre Connelly became a rising star at GlaxoSmithKline Plc (GSK) by helping the company survive a scandal. Her future may be clouded by a more basic challenge: Glaxo's struggle to sell medicine in its biggest market. Glaxo's U.S. pharmaceutical sales have fallen 16 percent since 2009, when Connelly, 54, took over as head of North American pharmaceuticals.

Novartis Leukemia Treatment Yields High Remission Rate

bloomberg.com — A new leukemia immune treatment being developed by Novartis AG (NOVN) led to the disappearance of cancer in 90 percent of patients, a study showed. The therapy, a process that involved taking a patient's T cells and reprogramming them to hunt cancer cells, resulted in complete remission of 27 of 30 patients with acute lymphoblastic leukemia, a deadly pediatric cancer, according to the study published today by the New England Journal of Medicine.

AbbVie Reconsidering Shire Sends Inversion Targets Down

bloomberg.com — AstraZeneca Plc and other health-care companies considered to be tax-friendly takeover targets fell after U.S. pharmaceutical company AbbVie Inc. (ABBV) said it was reconsidering its $51.5 billion bid for Shire Plc. (SHP) AstraZeneca, a London-based drugmaker that spurned a takeover offer from Pfizer Inc. (PFE) this year, dropped 3.5 percent to 42.54 pounds at 9:22 a.m.

For Nobel Prize Winner Betzig, Quitting Let Best Ideas Prosper

bloomberg.com — Want to win a Nobel Prize? Quit your day job. That worked for Eric Betzig, at least, who is part of a trio of scientists recognized with the Nobel in chemistry today for devising ways for microscopes to look into the molecular hearts of living cells.

Three scientists win the Nobel prize for chemistry for advances in nanoscopy

smh.com.au — Trailblazers in nanoscopy: A screen showing the laureates of the 2014 Nobel prize for chemistry, American scientists Eric Betzig (left) and William Moerner (right) and Germany's Stefan Hell. Photo: Reuters Two Americans and a German won the Nobel prize in chemistry for work that allows optical microscopes to study cells in the tiniest molecular detail, aiding in research of diseases such as Parkinson's and Alzheimer's.

Three Scientists Win Chemistry Nobel for Nanoscopy Work

bloomberg.com — Two Americans and a German won the Nobel Prize in Chemistry today for work that allows optical microscopes to study cells in the tiniest molecular detail, aiding in research of diseases such as Parkinson's and Alzheimer's.
More Articles →
Oct 24, 2014

We seem to have arrived in NYC just in time for #Ebola. So much for our bowling outing.

Oct 23, 2014

There but for the grace of god go I RT@romenesko: Meet the health-care reporter who works at McDonald's on weekends. bit.ly/1DF4pvf

Oct 22, 2014

Falcons playing in London. Or Barcelona. Maybe. RT @Deadspin The Atlanta Falcons don't know where London is deadspin.com/graphic-the-at…

Oct 22, 2014

The #WorldSeries winner usually isn't the best team in baseball. Let's reward regular season champions, too. percivalhenry.wordpress.com/2014/10/21/the…

Oct 22, 2014

RT @insidehighered: More Ebola concern at colleges -- U. of South Florida cancels visit by African journalists: insidehighered.com/quicktakes/201…

Oct 22, 2014

Survivors of #Ebola are now volunteering with patients, testing the theory they are immune, via @maki_kitamura bloomberg.com/news/2014-10-2…

Oct 22, 2014

Hey @SouthernRailUK , I'm getting a little tired of your "apologies" for late and canceled trains. How about a refund instead?

Oct 22, 2014

Deirdre Connelly, a rising star at $GSK, is under pressure as US drug sales falter bloom.bg/1wsz7Fw (resposting from late y'day)

Are You a Journalist?

Make a Portfolio

Create a free Muck Rack account to customize your profile and upload a portfolio of your best work.


For instructions on how to pitch Oliver Staley, email ostaley@muckrack.com.

Share This Profile